Search Results 2201-2210 of 20141 for Receptor

1. Publications - Cinthya J. Zepeda Mendoza, Ph.D. - Mayo Clinic

   Estrogen-related receptor gamma implicated in a phenotype including hearing loss and mild developmental delay. Eur J Hum Genet. 2016 Nov; 24 (11):1622-1626 ...

2. A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

   ... receptor (EGFR) mutations or anaplastic lymphoma kinase (ALK) rearrangements must have failed or are intolerant to prior treatment with EGFR or ALK ...

3. A Study to Evaluate the Safety, Effectiveness and Microbiological Response of Orally Administered ABI-M201 in Subjects with Mildly-to-Moderately Active Ulcerative Colitis with Ongoing Mesalamine Treatment - Mayo Clinic

   Use of proton pump inhibitors (PPIs) and histamine 2 receptor antagonists (H2RAs) ≤ 2 weeks prior to baseline visit and during study duration. Diagnosis of ...

4. A Study of ASP8273 versus Erlotinib or Gefitinib as First-Line Treatment for Patients with Stage IIIB/IV Non-Small Cell Lung Cancer - Mayo Clinic

   ... receptor (EGFR) activating mutations. This study will also assess overall survival, overall response rate, progression free survival assessed by the ...

5. Study Of AZD5863 In Adult Participants With Advanced Or Metastatic Solid Tumors - Mayo Clinic

   ... receptor T (CAR-T) cell therapy * Previous history of hemophagocytic lymphohistiocytosis (HLH) / macrophage activation syndrome (MAS) * Active or prior ...

6. Neurosurgery - Clinical trials

   Memantine hydrochloride may enhance cognitive function by binding to and inhibiting channels of receptors located in the central nervous system. Radiation ...

7. MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) - Mayo Clinic

   ... receptor agonist and lenalidomide, with a maximum limit of 1 month of exposure. * Note: Participants receiving hydroxyurea prior to treatment substudy or ...

8. Breast and Melanoma Surgical Oncology in Rochester - Clinical trials

   The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell ...

9. Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer (FRAPPE) - Mayo Clinic

   About this study. The purpose of this study is to determine the response rate to the combination of folate receptor alpha dendritic cells (FRaDCs) plus ...

10. Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure - Mayo Clinic

    Beta blocker therapy and ACE inhibitor or angiotensin receptor blocker (ARB) or sacubitril/valsartan combination therapy (Entresto) for ≥ 90 days prior to ...